Amgen notifies R&D staff that re-allocation of resources in the works
This article was originally published in Scrip
Executive Summary
Amgen has informed its research and development staff that it is reviewing "some changes" to its R&D programmes, and while details are sparse at the moment, analysts are already speculating that it could include budget cuts but that is by no means certain.